Nuveen, LLC Annexon, Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 347,032 shares of ANNX stock, worth $607,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
347,032Holding current value
$607,306% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ANNX
# of Institutions
152Shares Held
96.8MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$13 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$12.3 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$11.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$11 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$9.85 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $83.3M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...